TD ASSET MANAGEMENT INC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 207 filers reported holding DENALI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,785,050
+11.8%
135,000
+59.9%
0.00%0.0%
Q2 2023$2,491,293
+22.4%
84,422
-4.4%
0.00%
+50.0%
Q1 2023$2,034,939
-26.2%
88,322
-11.0%
0.00%
-33.3%
Q4 2022$2,759,002
+0.1%
99,209
+5.4%
0.00%0.0%
Q3 2022$2,757,000
-22.7%
94,123
-22.4%
0.00%
-25.0%
Q2 2022$3,568,000
-16.6%
121,223
-8.9%
0.00%0.0%
Q1 2022$4,280,000
-21.6%
133,037
+8.7%
0.00%
-20.0%
Q4 2021$5,456,000
-14.7%
122,337
-3.5%
0.01%
-28.6%
Q3 2021$6,399,000
-1.1%
126,8370.0%0.01%0.0%
Q2 2021$6,472,000
-19.5%
126,837
-9.9%
0.01%
-22.2%
Q1 2021$8,042,000
-28.3%
140,837
+5.2%
0.01%
-35.7%
Q4 2020$11,209,000
+216.2%
133,824
+35.3%
0.01%
+180.0%
Q3 2020$3,545,000
+154.5%
98,944
+71.8%
0.01%
+150.0%
Q2 2020$1,393,000
+143.1%
57,607
+76.1%
0.00%
+100.0%
Q1 2020$573,000
+37.1%
32,707
+36.3%
0.00%0.0%
Q4 2019$418,000
+13.6%
24,0000.0%0.00%0.0%
Q3 2019$368,000
-27.7%
24,000
-2.0%
0.00%0.0%
Q2 2019$509,000
-6.3%
24,500
+4.7%
0.00%0.0%
Q1 2019$543,000
+14.8%
23,400
+2.2%
0.00%0.0%
Q4 2018$473,000
-2.9%
22,900
+2.2%
0.00%0.0%
Q3 2018$487,000
+94.8%
22,400
+36.6%
0.00%
Q2 2018$250,000
-22.6%
16,4000.0%0.00%
Q1 2018$323,00016,4000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders